HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Ahn, S. -H. [1 ]
Marcellin, P. [2 ]
Ma, X. [3 ]
Caruntu, F. [4 ]
Tak, W. Y. [5 ]
Elkhashab, M. [6 ]
Chuang, W. -L. [7 ]
Tabak, F. [8 ]
Mehta, R. [9 ]
Petersen, J. [10 ]
Corsa, A. [11 ]
Martins, E. B. [11 ]
Yee, L. J. [11 ]
Dinh, P. [11 ]
Subramanian, G. Mani [11 ]
Buti, M. [12 ]
Gaeta, G. [13 ]
Papatheodoridis, G. [14 ]
Flisiak, R. [15 ]
Chan, H. L. Y. [16 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Univ Paris Diderot, Hop Beaujon, Clichy, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Natl Inst Infect Dis Prof Dr Matei Bals, Bucharest, Romania
[5] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[6] Toronto Liver Ctr, Toronto, ON, Canada
[7] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[8] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey
[9] Liver Clin, Surat, India
[10] Univ Hamburg, Hamburg, Germany
[11] Gilead Sci, Foster City, CA USA
[12] Hosp Univ Vall dHebron, Barcelona, Spain
[13] Univ Naples 2, Naples, Italy
[14] Univ Athens, Sch Med, Athens, Greece
[15] Med Univ Bialystok, Bialystok, Poland
[16] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00924-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-256
引用
收藏
页码：S524 / S525
页数：2
相关论文
共 50 条
  • [41] HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
    Yu, Ming-Lung
    Lee, Chuan-Mo
    Chuang, Wan-Long
    Lu, Sheng-Nan
    Dai, Chia-Yen
    Huang, Jee-Fu
    Lin, Zu-Yau
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Hung, Chao-Hung
    Wang, Jin-Houng
    Chen, Chi-Ling
    Kao, Jia-Horng
    Lai, Ming-Yang
    Liu, Chen-Hua
    Su, Tung-Hung
    Wu, Shun-Sheng
    Liao, Li-Ying
    Kuo, Hsing-Tao
    Chao, You-Chen
    Tung, Shui-Yi
    Yang, Sien-Sing
    Chen, Pei-Jer
    Liu, Chun-Jen
    Chen, Ding-Shinn
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (01): : 86 - 92
  • [42] Randomized controlled trial of Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients.
    Thakeb, FIA
    Omar, MM
    El Awady, MM
    Isshak, SY
    HEPATOLOGY, 2003, 38 (04) : 278A - 278A
  • [43] Randomized, Double-Blind, Placebo-Controlled Trial of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB)
    Chang, Mei-Hwei
    Park, Jae Hong
    Bezerra, Jorge A.
    Pacurar, Daniela
    Nijhawan, Sandeep
    Choe, Byung-Ho
    Kim, Kyung Mo
    Mehta, Rajiv M.
    Flaherty, John F.
    Wu, George
    Liu, Yang
    Reyes, Maribel
    Suri, Vithika
    Constantinescu, Alexandrina
    Choe, Yon-Ho
    Leung, Daniel H.
    HEPATOLOGY, 2018, 68 : 49A - 49A
  • [44] Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial
    Hou, J. L.
    Gao, Z. L.
    Xie, Q.
    Zhang, J. M.
    Sheng, J. F.
    Cheng, J.
    Chen, C. W.
    Mao, Q.
    Zhao, W.
    Ren, H.
    Tan, D. M.
    Niu, J. Q.
    Chen, S. J.
    Pan, C.
    Tang, H.
    Wang, H.
    Mao, Y. M.
    Jia, J. D.
    Ning, Q.
    Xu, M.
    Wu, S. M.
    Li, J.
    Zhang, X. X.
    Ji, Y.
    Dong, J.
    Li, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 85 - 93
  • [45] HIGH RATE OF HBSAG LOSS AND HBSAG SEROCONVERSION IN CHRONIC HEPATITIS B PATIENTS ON COMBINATION THERAPY WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA®): HBSAG TITER PREDICTS HBSAG LOSS OR SEROCONVERSION
    Takkenberg, Bart
    Zaaijer, Hans L.
    Weegink, Christine J.
    Terpstra, Volesko
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2008, 48 (04) : 1026A - 1027A
  • [46] Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Su, Tung-Hung
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2012, 56 : 993A - 993A
  • [47] Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
    Liu, Chun-Jen
    Chuang, Wan-Long
    Lee, Chuan-Mo
    Yu, Ming-Lung
    Lu, Sheng-Nan
    Wu, Shun-Sheng
    Liao, Li-Ying
    Chew, Chi-Ling
    Kuo, Hsing-Tao
    Chao, You-Chen
    Tung, Shui-Yi
    Yang, Sien-Sing
    Kao, Jia-Horng
    Liu, Chen-Hua
    Su, Wei-Wen
    Lin, Chih-Lin
    Jeng, Yung-Ming
    Chen, Pei-Jer
    Chen, Ding-Shinn
    GASTROENTEROLOGY, 2009, 136 (02) : 496 - 504
  • [48] Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C:: a randomized controlled trial
    Bruno, S
    Cammà, C
    Di Marco, V
    Rumi, M
    Vinci, M
    Camozzi, M
    Rebucci, C
    Di Bona, D
    Colombo, M
    Craxì, A
    Mondelli, MU
    Pinzello, G
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 474 - 481
  • [49] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
    Mingxing Huang
    Yusheng Jie
    Guoli Lin
    Hong Shi
    Xinhua Li
    Xiangyong Li
    Yuankai Wu
    Yutian Chong
    Clinical Drug Investigation, 2016, 36 : 471 - 478
  • [50] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Sandoval, J.
    Mata, J.
    Gaytan, J.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25
12345